Dopamine and alcohol relapse: D1 and D2 antagonists increase relapse rates in animal studies and in clinical trials.
A considerable number of animal studies on the effects of dopaminergic agents on alcohol intake behavior have been performed. Acute alcohol administration in rats induces dopamine release in the caudate nucleus and in the nucleus accumbens, an effect related among others to reinforcement. It has been repeatedly suggested that D1 and D2 receptor activation mediates reward. As alcohol consumption and dopaminergic transmission seem to have a close relationship, all kinds of dopaminergic agents may be regarded as putative therapeutics for preventing relapse. In a prospective European double-blind multicenter clinical trial, comparing the D1, D2, D3 antagonist flupenthixol and placebo in 281 chronic alcohol-dependent patients (27.4% women), the application of the Lesch typology made an outcome differentiation possible. It could be shown in which patients flupenthixol administration was followed by a significantly higher relapse rate and in which patient groups no differences were found when compared to placebo.
Walter
H
H
Department of Psychiatry, University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria. Henriette.Walter@akh-wien.ac.at
Ramskogler
K
K
Semler
B
B
Lesch
O M
OM
Platz
W
W
D000437:Alcoholism / Q000145:classification / Q000209:etiology*; D000818:Animals; D002986:Clinical Trials as Topic; D018492:Dopamine Antagonists / Q000009:adverse effects*; D065127:Dopamine D2 Receptor Antagonists; D006801:Humans; D023421:Models, Animal; D017447:Receptors, Dopamine D1 / Q000037:antagonists & inhibitors; D012008:Recurrence
D018492:Dopamine Antagonists; D065127:Dopamine D2 Receptor Antagonists; D017447:Receptors, Dopamine D1